bms-986156
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 9, 2015 (NCT02598960)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
TNFRSF18 inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297568 ↗
Also known as
- bms-986156
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04021043 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2019 | University of Texas at Houston |
| NCT03335540 | Phase 1 | Mar 13, 2018 | Bristol-Myers Squibb |
| NCT02598960 | Phase 1/Phase 2 (Phase 2) | Oct 9, 2015 | Bristol-Myers Squibb |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 2 | 2 | 2 | 2015 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1